標題: Titlebook: Clinician’s Manual on Myelodysplastic Syndromes; Alan List Book 2008 Springer Healthcare Ltd. 2008 Clinical.Hematology.Manual.Reference.cl [打印本頁] 作者: Forestall 時間: 2025-3-21 17:43
書目名稱Clinician’s Manual on Myelodysplastic Syndromes影響因子(影響力)
書目名稱Clinician’s Manual on Myelodysplastic Syndromes影響因子(影響力)學(xué)科排名
書目名稱Clinician’s Manual on Myelodysplastic Syndromes網(wǎng)絡(luò)公開度
書目名稱Clinician’s Manual on Myelodysplastic Syndromes網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Clinician’s Manual on Myelodysplastic Syndromes被引頻次
書目名稱Clinician’s Manual on Myelodysplastic Syndromes被引頻次學(xué)科排名
書目名稱Clinician’s Manual on Myelodysplastic Syndromes年度引用
書目名稱Clinician’s Manual on Myelodysplastic Syndromes年度引用學(xué)科排名
書目名稱Clinician’s Manual on Myelodysplastic Syndromes讀者反饋
書目名稱Clinician’s Manual on Myelodysplastic Syndromes讀者反饋學(xué)科排名
作者: 步履蹣跚 時間: 2025-3-21 20:57 作者: 狂怒 時間: 2025-3-22 03:04
Classification of myelodysplastic syndromes,In 1982, the first morphologic classification system of MDS was reported作者: Insufficient 時間: 2025-3-22 05:47 作者: 能量守恒 時間: 2025-3-22 12:44
https://doi.org/10.1007/978-81-322-2665-9ation, with some evidence, albeit limited, supporting genetic predisposition in younger individuals. Secondary disease is specifically associated with cytoxic chemotherapy. The principal contributing factor may also be associated with intrinsic aging processes [6].作者: 可忽略 時間: 2025-3-22 12:59
https://doi.org/10.1007/978-3-030-55362-3y of diseases and conditions may cause anemia and other cytopenias, tests are required to exclude these and confirm the presence of MDS (Figure 4.1), and to delineate patients’ prognoses. Each of these factors is an important consideration when developing a treatment strategy. Recommended investigations include [10]:作者: 可忽略 時間: 2025-3-22 20:59 作者: 平 時間: 2025-3-22 22:14
Clinical assessment and diagnosis,y of diseases and conditions may cause anemia and other cytopenias, tests are required to exclude these and confirm the presence of MDS (Figure 4.1), and to delineate patients’ prognoses. Each of these factors is an important consideration when developing a treatment strategy. Recommended investigations include [10]:作者: habile 時間: 2025-3-23 05:02
Book 2008vailable and analyses the potential for new treatments.- High quality clinical photos and figures to enhance descriptions and improve reader comprehension.- Useful reference text for healthcare professionals needing to know more about myelodysplastic syndromes.作者: 挑剔小責(zé) 時間: 2025-3-23 08:26
urrently available and analyses the potential for new treatments.- High quality clinical photos and figures to enhance descriptions and improve reader comprehension.- Useful reference text for healthcare professionals needing to know more about myelodysplastic syndromes.978-1-85873-427-9978-1-907673-36-8作者: 細微差別 時間: 2025-3-23 11:59 作者: ARM 時間: 2025-3-23 14:13 作者: Eulogy 時間: 2025-3-23 19:44
http://image.papertrans.cn/c/image/228331.jpg作者: 矛盾 時間: 2025-3-23 23:11
https://doi.org/10.1007/978-81-322-2665-9d morphologically, MDS are characterized by dysplastic and ineffective hematopoiesis, resulting in peripheral blood cytopenias and an increased risk for transformation to AML. Despite an increased fraction of proliferating cells, MDS bone marrow progenitors display impaired differentiation potential作者: 捕鯨魚叉 時間: 2025-3-24 02:47 作者: 四指套 時間: 2025-3-24 10:28
Vicente Raga Rosaleny,Plínio Junqueira Smithstages of disease, patients are often asymptomatic and a diagnosis of MDS is discovered incidentally during a routine blood analysis. In the later stages of disease, patients may present with symptoms of anemia, neutropenia or thrombocytopenia, or some combination. In fact, at least one-half of pati作者: 墊子 時間: 2025-3-24 14:26
https://doi.org/10.1007/978-3-030-55362-3y of diseases and conditions may cause anemia and other cytopenias, tests are required to exclude these and confirm the presence of MDS (Figure 4.1), and to delineate patients’ prognoses. Each of these factors is an important consideration when developing a treatment strategy. Recommended investigat作者: 工作 時間: 2025-3-24 17:26 作者: 事與愿違 時間: 2025-3-24 22:44 作者: 軟弱 時間: 2025-3-25 02:23
Signs and symptoms of myelodysplastic syndromes,stages of disease, patients are often asymptomatic and a diagnosis of MDS is discovered incidentally during a routine blood analysis. In the later stages of disease, patients may present with symptoms of anemia, neutropenia or thrombocytopenia, or some combination. In fact, at least one-half of pati作者: 有惡意 時間: 2025-3-25 05:17
Clinical assessment and diagnosis,y of diseases and conditions may cause anemia and other cytopenias, tests are required to exclude these and confirm the presence of MDS (Figure 4.1), and to delineate patients’ prognoses. Each of these factors is an important consideration when developing a treatment strategy. Recommended investigat作者: Progesterone 時間: 2025-3-25 08:42
urrently available and analyses the potential for new treatments.- High quality clinical photos and figures to enhance descriptions and improve reader comprehension.- Useful reference text for healthcare professionals needing to know more about myelodysplastic syndromes.978-1-85873-427-9978-1-907673作者: 意外 時間: 2025-3-25 12:15 作者: Galactogogue 時間: 2025-3-25 16:32 作者: Toxoid-Vaccines 時間: 2025-3-25 23:32
Introduction to myelodysplastic syndromes,, accelerated apoptosis (or programmed cell death), and, as a consequence, bone marrow failure (Figure 1.1). The net clinical result is ineffective hematopoiesis with intractable peripheral cytopenias: anemia, thrombocytopenia, and/or neutropenia.作者: Pseudoephedrine 時間: 2025-3-26 01:07
Signs and symptoms of myelodysplastic syndromes,ents have pancytopenia at the time of diagnosis [6]. The severity of symptoms and disease manifestations, which range from mild to life-threatening, adversely affect the patient’s quality of life (QoL) [4,24,25].作者: 表皮 時間: 2025-3-26 04:33
Book 2008vailable and analyses the potential for new treatments.- High quality clinical photos and figures to enhance descriptions and improve reader comprehension.- Useful reference text for healthcare professionals needing to know more about myelodysplastic syndromes.作者: 錯誤 時間: 2025-3-26 11:08
7樓作者: Airtight 時間: 2025-3-26 14:43
8樓作者: Obligatory 時間: 2025-3-26 19:25
8樓作者: 終止 時間: 2025-3-26 21:41
8樓作者: 反感 時間: 2025-3-27 01:46
9樓作者: Indebted 時間: 2025-3-27 06:47
9樓作者: appall 時間: 2025-3-27 10:21
9樓作者: 向宇宙 時間: 2025-3-27 16:23
9樓作者: otic-capsule 時間: 2025-3-27 20:04
10樓作者: Diluge 時間: 2025-3-28 01:40
10樓作者: Traumatic-Grief 時間: 2025-3-28 04:15
10樓作者: Delude 時間: 2025-3-28 07:48
10樓
